Tumor necrosis factor α and lymphotoxin α are not required for induction of acute experimental autoimmune encephalomyelitis

Journal of Experimental Medicine

Volumn 185, Issue 12, 1997, Pages 2177-2182

  Frei, Karl ^a   Eugster, Hans Pietro ^a   Bopst, Martin ^b   Constantinescu, Cris S ^c   Lavi, Ehud ^c   Fontana, Adriano ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATION; GENE INDUCTION; IMMUNIZATION; MICROGLIA; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR GENE; T LYMPHOCYTE ACTIVATION;

ACUTE DISEASE; ANIMALS; AUTOIMMUNITY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; LYMPHOTOXIN-ALPHA; MICE; MICE, INBRED C57BL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030918326     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.12.2177     Document Type: Article

References (37)

1. Issazadeh, S., Å. Ljungdahl, B. Höjeberg, M. Mustafa, and T. Olsson. 1995. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor α and tumor necrosis factor β. J. Neuroimmunol. 61:205-212.
2. Renno, T., M. Krakowski, C. Piccirillo, J. Lin, and T. Owens. 1995. TNF-α expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. J. Immunol. 154:944-953.
3. Baker, D., J.K. O'Neill, and J.L. Turk. 1991. Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis. Cell. Immunol. 134: 505-510.
4. Held, W., R. Meyermann, Y. Qin, and C. Mueller. 1993. Perforin and tumor necrosis factor α in the pathogenesis of experimental allergic encephalomyelitis: comparison of autoantigen induced and transferred disease in Lewis rats. J. Autoimmun. 6:311-322.
5. Okuda Y., Y. Nakatsuji, H. Fujimura, H. Esumi, T. Ogura, T. Yanagihara, and S. Sakoda. 1995. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J. Neuroimmunol. 62:103-112.
6. Ruddle, N.H., C.M. Bergman, K.M. McGrath, E.G. Lingenheld, M.L. Grunnet, S.J. Padula, and R.B. Clark. 1990. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1193-1200.
7. Selmaj, K., C.S. Raine, and A.H. Cross. 1991. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol. 30:694-700.
8. Selmaj, K., W. Papierz, A. Glabinski, and T. Kohno. 1995. Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I. J. Neuroimmunol. 56:135-141.
9. Martin, D., S.L. Near, A. Bendele, and D.A. Russell. 1995. Inhibition of tumor necrosis factor is protective against neurologic dysfunction after active immunization of Lewis rats with myelin basic protein. Exp. Neurol. 131:221-228.
10. Powell, M.B., D. Mitchell, J. Lederman, J. Buckmeier, S.S. Zamvil, M. Graham, N.H. Ruddle, and L. Steinman. 1990. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol. 2:539-544.
11. Chung, I.Y., J.G. Norris, and E.N. Benveniste. 1991. Differential tumor necrosis factor α expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains. J. Exp. Med. 173:801-811.
12. Robbins, D.S., Y. Shirazi, B.-E. Drysdale, A. Lieberman, H.S. Shin, and M.L. Shin. 1987. Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J. Immunol. 139:2593-2597.
13. Selmaj, K.W., and C.S. Raine. 1988. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:339-346.
14. Probert, L., K. Akassoglou, M. Pasparakis, G. Kontogeorgos, and G. Kollias. 1995. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system - specific expression of tumor necrosis factor-α. Proc. Natl. Acad. Sci. USA. 92:11294-11298.
15. Kuroda, Y., and Y. Shimamoto. 1991. Human tumor necrosis factor-α augments experimental allergic encephalomyelitis in rats. J. Neuroimmunol. 34:159-164.
16. Crisi, G.M., L. Santambrogio, G.M. Hochwald, S.R. Smith, J.A. Carlino, and G.J. Thorbecke. 1995. Staphylococcal enterotoxin B and tumor necrosis factor-α-induced relapses of experimental allergic encephalomyelitis: protection by transforming growth factor-β and interleukin-10. Eur. J. Immunol. 25:3035-3040.
17. Eugster, H.-P., M. Müller, U. Karrer, B.D. Car, B. Schnyder, V.M. Eng, G. Woerly, M. Le Hir, F. di Padova, M. Aguet et al. 1996. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double deficient mice. Int. Immunol. 8:23-36.
18. Brocke, S., K. Gijbels, and L. Steinman. 1994. Experimental autoimmune encephalomyelitis in the mouse. In Autoimmune Disease Models. A Guide Book. I.R. Cohen and A. Miller, editors. Academic Press, San Diego. 1-14.
19. Brown, A.M., and D.E. Mc Farlin. 1981. Relapsing experimental allergic encephalomyelitis in the SJL/J mouse. Lab. Invest. 45:278-284.
20. Al-Sabbagh, A., A. Miller, L.M.B. Santos, and H.L. Weiner. 1994. Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse. Eur. J. Immunol. 24:2104-2109.
21. Teuscher, C., W.F. Hickey, and R. Korngold. 1990. An analysis of the role of tumor necrosis factor in the phenotypic expression of actively induced experimental allergic orchitis and experimental allergic encephalomyelitis. Clin. Immunol. Immunopathol. 54:442-453.
22. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenolchloroform extraction. Anal. Biochem. 162:156-159.
23. Beutler, B., and Cerami, A. 1986. Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature (Lond.). 320:584-588.
24. Ferber, I.A., S. Brocke, C. Taylor-Edwards, W. Ridgway, C. Dinisco, L. Steinman, D. Dalton, and C.G. Fathman. 1996. Mice with a disrupted IFN-γ gene are susceptible for the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156:5-7.
25. Krakowski, M., and T. Owens. 1996. Interferon-γ confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26:1641-1646.
26. Willenborg, D.O., S. Fordham, C.C.A. Bernard, W.B. Cowden, and I.A. Ramshaw. 1996. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157:3223-3227.
27. Le Hir, M., H. Bluethmann, M. Kosco-Vilbois, M. Müller, F. Di Padova, M. Moore, B. Ryffel, and H.P. Eugster. 1996. Differentiation of follicular dendritic cells (FDC) and full antibody responses require TNF receptor-1 (TNFR-1) signaling. J. Exp. Med. 183:2367-2372.
28. Ryffel, B., M. Le Hir, F. di Padova, M.H. Schreier, M. Mueller, H.P. Eugster, and V.F.J. Quesniaux. 1997. Defective Ig isotype switch to both T-cell dependent and independent antigens in TNF/LT-α deficient mice. J. Immunol. 158: 2126-2133.
29. Linington, C., M. Bradl, H. Lassmann, C. Brunner, and K. Vass. 1988. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am. J. Pathol. 130:443-454.
30. Wolf, S.D., B.N. Dittel, F. Hardardottir, and C.A. Janeway. 1996. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184: 2271-2278.
31. Merrill, J.E., D.H. Kono, J. Clayton, D.G. Ando, D.R. Hinton, and F.M. Hofman. 1992. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10. PL mice. Proc. Natl. Acad. Sci. USA. 89:574-578.
32. Willenborg, D.O., S.A. Fordham, W.B. Cowden, and I.A. Ramshaw. 1995. Cytokines and murine autoimmune encephalomyelitis: inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system. Scand. J. Immunol. 41:31-41.
33. Paya, C.V., P.J. Leibson, A.K. Patick, and M. Rodriguez. 1990. Inhibition of Theiler's virus-induced demyelination in vivo by tumor necrosis factor alpha. Int. Immunol. 2:909-913.
34. Agresti, C., D. D'Urso, and G. Levi. 1996. Reversible inhibitory effects of interferon-γ and tumor necrosis factor-α on oligodendroglial lineage cell proliferation and differentiation in vitro. Eur. J. Neurosci. 8:1106-1116.
35. Wilson, M.A., and S. Tonegawa. 1997. Synaptic plasticity, place cells and spatial memory: study with second generation knockouts. Trends Neurosci. 20:102-106.
36. Selmaj, K., C.S. Raine, B. Cannella, and C.F. Brosnan. 1991. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87:949-954.
37. Beck, J., P. Rondot, L. Catinot, E. Falcoff, H. Kirchner, and J. Wietzerbin. 1988. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol. Scand. 78:318-323.